biopharmaceutical industry News
-
A Simple Guide to Nailing your BioPharma Interview
Landing a job in the biopharmaceutical industry can be a competitive process. With so many qualified candidates vying for the same position, it’s important to stand out from the crowd and make sure your interviewers know that you are a great fit for their company. Here are some tips to help you ace your biopharma interview and land the job of your dreams. Do Your ...
By Brio Group
-
Overview Article on Biotech and Medical Applications
After several years of intense research in close collaboration international partners from both, medical research and biopharmaceutical companies, Ionimed Analytik has released an overview articel, summarizing this work. This technical article Applications of PTR-MS in Medicine and Biotechnology has been published in American Laboratory (Tuesday, June 14, 2011) and is available online via this ...
-
In the Midst of a Pandemic, Why is the House of Representatives Trying to Undermine Biopharmaceutical Innovation?
Tom DiLenge, President, Advocacy, Law and Public Policy, of the Biotechnology Innovation Organization (BIO), released the following statement regarding the prescription drug provisions in the Patient Protection and Affordable Care Enhancement Act (HR 1425): “More than two-and-a-half million individuals across the country have been infected by the novel coronavirus and countless more have ...
-
Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale
New York, United States—Oct 10, 2022—Creative Peptides, the leading biotechnology company focusing on peptides, today announces to provide ready-to-ship Fmoc-Tyr(HP03Bzl)-OH products with 90% and 95% purities, which can be ordered in small amounts or large scale according to client demand. “Our peptide chemists have successfully manufactured Fmoc-Tyr(HP03Bzl)-OH with purities of 90% and 95%. We ...
-
Kallyope Announces CEO Transition as Company Advances to its Next Stage of Growth
Kallyope Inc., a leading biotechnology company focused on identifying and pursuing novel therapeutics involving the gut-brain axis, today announced that the Board of Directors has appointed Jay Galeota as President and he will succeed Nancy Thornberry as Chief Executive Officer by October 1, 2021. Mr. Galeota also joins the Kallyope Board of Directors. Ms. Thornberry will remain actively involved ...
-
Novadiscovery announces new clinical simulation collaboration with Takeda
Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a new collaboration with “Takeda Pharmaceutical Company Limited (“Takeda”) aimed at incorporating clinical simulation technology on virtual ...
-
Matica Bio Opens New Cell & Gene Therapy GMP Facility in Texas
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other ...
-
Stem Pharm Awarded $1.7M NIH SBIR Grant for Better Models of the Brain
Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health (NIH) to optimize its induced pluripotent stem cell (iPSC)-derived model of the central nervous system for drug discovery and toxicology applications. Stem Pharm’s model fills a commercial need to accurately reflect the complexity of cell ...
-
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and Innoforce, a bioinnovation-enabling company, today announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing. The new facility is expected to be completed in 2022. The new ...
-
Building a New Generation AI Engine and Jointly Accelerating World-Class Innovative Drug Discovery and Development
Regor Therapeutics Group and NVIDIA Corporation today entered into collaboration that makes Regor Therapeutics Group a unique biotech company in China to have in-depth access to NVIDIA Inception. Regor Therapeutics Group will work closely with NVIDIA to integrate high performance computing technology into Regor's proprietary Artificial Intelligence innovation platform - rCARDTM - to accelerate ...
-
Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows
Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry in areas including personalized medicine, monoclonal antibodies and gene and cell therapies. ...
-
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accelerate Scientific Breakthroughs
Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base. Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi ...
-
LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology
DUSSELDORF, Germany, February 14, 2019 – LenioBio GmbH announces the appointment of Dr. Lorenz M. Mayr, Prof. Govind Rao, and Prof. Stefan Schillberg to LenioBio’s Scientific Advisory Board (SAB). LenioBio is a German life sciences start-up dedicated to the advancement of a transformative technology for the discovery, development, and expression of ‘difficult-to-produce’ ...
-
Ensuring Scientific Justice by Building Bridges to Minority Communities is Centerpiece of BIOEquality Agenda
The Biotechnology Innovation Organization (BIO) today announced BIOEquality Agenda which aims to attack the systemic inequality, injustice and unfair treatment of women and communities of color through the positive force of biotechnology. Recognizing that gains from transformative science are not always shared equally, BIO is challenging the industry, and its partners, to find solutions for ...
-
Matica Bio Announces Joint Research Agreement with Sartorius for the Development of Advanced Viral Vector Manufacturing Technology
Matica Biotechnology, Inc, (Matica Bio) a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced a joint research agreement (JRA) with Sartorius, a leading international partner of the biopharmaceutical industry. Under this agreement, Matica Bio and Sartorius will work on a number of studies ...
-
As Companies Work Around the Clock to Address COVID-19, BIO Outlines Key Policy Priorities to Prevent the Next Pandemic
The Senate Committee on Health, Education, Labor and Pensions, chaired by Senator Lamar Alexander, will hold an important hearing today to examine lessons learned from the current global health crisis to help make sure we are better prepared for the next pandemic. Public health expert and patient advocate, Dr. Julie Gerberding, will join the discussion, alongside former top policy leaders. The ...
-
5 Signs of a Positive Company Culture
When a jobseeker is looking for a new role in the biotech, pharma, or CRO industry, they look beyond salary and location. A company’s culture is just as important—sometimes even more so—than the job itself. That’s why it’s important to recognize the signs of a positive company culture before you start your job search. Keep an eye out for these ...
By Brio Group
-
Altis Biosystems Announces New Research Funding Initiative
Durham, NC (September 16, 2021) – Altis Biosystems, Inc., developer of RepliGut®, a technology platform that produces a layer of primary human intestinal stem and/or differentiated cells of either the small intestine or colon, announced today a Research Funding Initiative focused on one unifying purpose: To accelerate research into complex diseases and aid researchers in unlocking ...
-
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
CD Formulation, a company in the field of biopharmaceutical studies, is revolutionizing the way impurity determination is conducted in the industry. With the use of advanced technology and cutting-edge methodologies, CD Formulation offers accurate and reliable testing for a wide range of impurities, ensuring the safety and effectiveness of pharmaceutical products. The expertise in organic ...
-
4 Things to Consider Before Hiring a Biopharma Recruiter
If you’re in the life science or biopharma industries, you know that hiring top talent is essential to your success. But with the war for talent heating up, it’s becoming increasingly difficult to find and attract the best candidates. One solution is to work with a biopharma recruiter. But before you hire a recruiter, there are a few things you should consider. Here are 5 things ...
By Brio Group
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you